Liang Jiaheng, Lv Ronghao, Li Maorui, Chai Jin, Wang Shuo, Yan Wenjun, Zheng Zijian, Li Peng
Frontiers Science Center for Flexible Electronics (FSCFE), Institute of Flexible Electronics (IFE), Institute of Biomedical Materials and Engineering (IBME), Northwestern Polytechnical University (NPU), Xi'an, 710072, China.
Laboratory for Advanced Interfacial Materials and Devices, Department of Applied Biology and Chemical Technology (ABCT), Research Institute for Intelligent Wearable Systems (RI-IWEAR), The Hong Kong Polytechnic University, Hong Kong, SAR, 999077, China.
Macromol Biosci. 2024 Feb;24(2):e2300302. doi: 10.1002/mabi.202300302. Epub 2023 Oct 17.
Cardiovascular diseases (CVDs) have become the leading global burden of diseases in recent years and are the primary cause of human mortality and loss of healthy life expectancy. Myocardial infarction (MI) is the top cause of CVDs-related deaths, and its incidence is increasing worldwide every year. Recently, hydrogels have garnered great interest from researchers as a promising therapeutic option for cardiac tissue repair after MI. This is due to their excellent properties, including biocompatibility, mechanical properties, injectable properties, anti-inflammatory properties, antioxidant properties, angiogenic properties, and conductive properties. This review discusses the advantages of hydrogels as a novel treatment for cardiac tissue repair after MI. The design strategies of various hydrogels in MI treatment are then summarized, and the latest research progress in the field is classified. Finally, the future perspectives of this booming field are also discussed at the end of this review.
近年来,心血管疾病(CVDs)已成为全球主要的疾病负担,并且是人类死亡和健康预期寿命损失的主要原因。心肌梗死(MI)是与CVDs相关死亡的首要原因,其发病率在全球范围内逐年上升。最近,水凝胶作为心肌梗死后心脏组织修复的一种有前景的治疗选择,引起了研究人员的极大兴趣。这是由于它们具有优异的特性,包括生物相容性、机械性能、可注射性、抗炎性、抗氧化性、血管生成性和导电性。本综述讨论了水凝胶作为心肌梗死后心脏组织修复的一种新型治疗方法的优势。接着总结了各种水凝胶在心肌梗死治疗中的设计策略,并对该领域的最新研究进展进行了分类。最后,本综述末尾还讨论了这个蓬勃发展领域的未来前景。